ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2020 American Transplant Congress

    CEACAM1 / ASK1 / p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura2, S. Kageyama1, T. Ito1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, R. W. Busuttil1, F. M. Kaldas1, J. Kupiec-Weglinski1

    1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan

    *Purpose: Although CEACAM1 (CM1; carcinoembryonic antigen-related cell adhesion molecule 1; CD66a) regulates hepatic metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains unknown. A…
  • 2020 American Transplant Congress

    Induction Immunosuppression with Thymoglobulin May Improve Graft Outcomes without Increasing a Risk for Infection in Patients Undergoing Liver Transplantation Alone

    M. Henry1, T. Kitajima2, J. Konel1, S. Yeddula2, M. Rizzari2, K. Collins2, D. Moonka2, A. Yoshida2, M. Abouljoud2, S. Nagai3

    1Wayne State University School of Medicine, Detroit, MI, 2Henry Ford Hospital, Detroit, MI, 3Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: Immunosuppression protocols for liver transplant (LT) vary between institutions and roles of induction immunosuppression in LT remain controversial. The aim of this study was…
  • 2020 American Transplant Congress

    Development of Novel Multivariable Logistic Regression Model for Predicting Graft Failure within 2 Weeks and 4 Weeks after Liver Transplantation Using Post-Transplantation Laboratory Values

    J. Kwon, S. Kim, G. Choi, J. Joh, J. Park, J. Rhu, K. Kim, O. Lee, M. Lim, E. Jeong, J. Yang

    Transplantation, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: This study designed a prediction model for graft failure after liver transplantation.*Methods: Multivariable logistic regression including aspartate aminotransferase (AST), total bilirubin (TB), and international…
  • 2020 American Transplant Congress

    Development of Recommendations for Liver Transplant Anesthesia Teams Using a Modified Delphi Process

    C. Crouch, A. Hendrickse, S. Mandell

    Department of Anesthesiology, University of Colorado, Aurora, CO

    *Purpose: We utilized a modified Delphi technique to develop recommendations to guide service responsibilities for liver transplant anesthesia teams (LTATs).*Methods: The Society for the Advancement…
  • 2020 American Transplant Congress

    The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality

    R. Batra1, D. Mulligan1, D. Haakinson1, S. Noreen2, D. Stewart2, G. Gan3, Y. Deng3, S. Kulkarni1

    1Surgery, Yale University School of Medicine, New Haven, CT, 2UNOS, Richmond, VA, 3Yale University, New Haven, CT

    *Purpose: Liver transplant waitlist mortality due to inadequate access to livers is the Achilles heel in liver transplantation in United States. This remains amongst the…
  • 2020 American Transplant Congress

    The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma

    M. L. Goldman1, K. Zhou2, J. L. Dodge1, F. Yao1, N. Mehta1

    1Department of Medicine, UCSF, San Francisco, CA, 2Department of Medicine, USC, Los Angeles, CA

    *Purpose: Under current UNOS policy, hepatocellular carcinoma (HCC) patients with alpha-fetoprotein (AFP) >1,000 ng/mL are required to show a reduction in AFP to 100 but
  • 2020 American Transplant Congress

    Opioid Prescription Pattern and Risk Factors Associated with Opioid Use after Living Donor Hepatectomy in the US

    M. Nguyen1, L. Vest2, Z. Zhang2, V. Whittaker3, M. Schnitzler1, D. Axelrod4, H. Randall1, C. Varma1, J. Snyder5, B. Kasiske5, D. Segev6, M. McAdams Demarco7, G. Hess8, K. Lentine2

    1Department of Surgery, Saint Louis University, Saint Louis, MO, 2Department of Medicine, Saint Louis University, Saint Louis, MO, 3Department of Surgery, New York Medical College, New York, NY, 4Department of Surgery, University of Iowa, Iowa City, IA, 5SRTR, Minneapolis, MN, 6Department of Surgery, Johns Hopkins University, Baltimore, MD, 7Johns Hopkins University, Baltimore, MD, 8Drexel University, Philadelphia, PA

    *Purpose: Opioids are the cornerstone of acute pain management after living donor hepatectomy. Their misuse poses the danger of chronic abuse. How this affects living…
  • 2020 American Transplant Congress

    Metabolism Reprogramming During Conventional versus Ischemia-Free Liver Transplantation

    Z. Guo1, Z. Zhang1, N. Gao1, H. Zhang2, X. He1

    1Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Sun Yat-sen University, Guangzhou, China

    *Purpose: Our group has developed a novel transplant procedure called ischemia-free liver transplantation (IFLT), during which the liver can be procured, preserved and implanted without…
  • 2020 American Transplant Congress

    Sparing the Nephron in Liver Transplant Recipients with Antithymocyte Bridging: A Four Year Experience

    N. Wilson, H. Kuzaro, N. Parrish, S. A. Shah, N. Anwar, R. R. Alloway, S. Tremblay, T. E. Kaiser

    U Cincinnati, Cincinnati, OH

    *Purpose: Renal function decline after liver transplant (LT) remains a significant issue. Using antithymocyte globulin (rATG) to delay tacrolimus (TAC) initiation may impact renal deterioration;…
  • 2020 American Transplant Congress

    A Liver Transplant Candidate with Above Average Conscientiousness is More Likely to Receive a Liver Transplant

    O. Siddiqui1, J. Lai2, D. Peipert1, T. Kaundinya1, A. Daud1, A. Hall1, D. Ganger1, R. Wong2, C. Loftus1, D. Mroczek1, D. Ladner1

    1Northwestern University, Chicago, IL, 2UCSF, San Francisco, CA

    *Purpose: Liver transplant (LT) candidates are currently assessed in terms of their physical, social and mental capacity to take care of themselves and their grafts.…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences